Cost effectiveness of left atrial appendage closure with the Watchman device for atrial fibrillation patients with absolute contraindications to warfarin

AIMS: Atrial fibrillation (AF) patients with contraindications to oral anticoagulation have had few options for stroke prevention. Recently, a novel oral anticoagulant, apixaban, and percutaneous left atrial appendage closure (LAAC) have emerged as safe and effective therapies for stroke risk reduct...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Europace
Huvudupphovsmän: Reddy, Vivek Y., Akehurst, Ronald L., Armstrong, Shannon O., Amorosi, Stacey L., Brereton, Nic, Hertz, Deanna S., Holmes, David R.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Oxford University Press 2016
Ämnen:
Clinical Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4927063/
https://ncbi.nlm.nih.gov/pubmed/26838691
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/europace/euv412
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk